Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Merck presents clinical data on COX-2 inhibitor at FASEB 98

April 28, 1998

New findings support the hypothesis that fetal cells are involved in scleroderma

April 28, 1998

Dupuytren's disease treatment shows promise in early clinical trials

April 28, 1998

Chemokine receptor antagonists developed at Banyu

April 24, 1998

Doxycycline to be evaluated for the treatment of osteoarthritis

April 23, 1998

PKC inhibitors for inflammatory, immune, allergic and other disorders described by Otsuka

April 22, 1998

Pharmacokinetics and pharmacodynamics of IDEC-151 reported at European rhematology meeting

April 22, 1998

New antirheumatic agent shown effective in long-term patient studies

April 22, 1998

Shire to market Fidia's new osteoarthritis treatment

April 21, 1998

Unexpected results from a study of gene therapy for rheumatoid arthritis

April 21, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...